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gonist-induced endocytosis and processing of the G
protein–coupled AT
 
1
 
 angiotensin II (Ang II) receptor
(AT
 
1
 
R) was studied in HEK 293 cells expressing
green ﬂuorescent protein (GFP)– or hemagglutinin epitope–
tagged forms of the receptor. After stimulation with Ang II,
the receptor and its ligand colocalized with Rab5–GFP and
Rab4–GFP in early endosomes, and subsequently with
Rab11–GFP in pericentriolar recycling endosomes. Inhibition
of phosphatidylinositol (PI) 3-kinase by wortmannin (WT)
or LY294002 caused the formation of large endosomal
vesicles of heterogeneous Rab composition, containing the
ligand–receptor complex in their limiting membranes
and in small associated vesicular structures. In contrast to
Alexa
 
®
 
–transferrin, which was mainly found in small vesicles
A
 
associated with the outside of large vesicles in WT-treated
cells, rhodamine–Ang II was also segregated into small
internal vesicles. In cells labeled with 
 
125
 
I-Ang II, WT
treatment did not impair the rate of receptor endocytosis, but
signiﬁcantly reduced the initial phase of receptor recycling
without affecting its slow component. Similarly, WT inhibited
the early, but not the slow, component of the recovery of
AT
 
1
 
R at the cell surface after termination of Ang II stimulation.
These data indicate that internalized AT
 
1
 
 receptors are pro-
cessed via vesicles that resemble multivesicular bodies, and
recycle to the cell surface by a rapid PI 3-kinase–dependent
recycling route, as well as by a slower pathway that is less
sensitive to PI 3-kinase inhibitors.
 
Introduction
 
The most important physiological actions of the octapeptide
hormone angiotensin II (Ang II)* are mediated by the type 1
Ang II receptor (AT
 
1
 
R). The AT
 
1
 
R is a member of the super-
family of G protein–coupled receptors (GPCRs), and pro-
motes inositol phosphate and calcium signaling via G
 
q/11
 
(De Gasparo et al., 2000). Ang II also causes rapid phos-
phorylation, desensitization, and endocytosis of the AT
 
1
 
R,
with subsequent intracellular processing and recycling to the
cell membrane (Thomas, 1999; Hunyady et al., 2000;
Ferguson, 2001). Previous studies have suggested that the
fates of the internalized hormone and the receptor differ in
that the ligand accumulates in lysosomes while the receptor
recycles to the cell surface (Hein et al., 1997).
Agonist-induced endocytosis of most GPCRs occurs
primarily via clathrin-coated vesicles (Ferguson, 2001). Pre-
vious studies suggested that internalization of the AT
 
1
 
R dif-
fers from that of 
 
 
 
-receptors in being dynamin- and 
 
 
 
-arrestin–
independent (Zhang et al., 1996), but at physiological
hormone concentrations, endocytosis of the AT
 
1
 
R occurs
predominantly via a 
 
 
 
-arrestin– and dynamin-dependent
mechanism (Anborgh et al., 2000; Gáborik et al., 2001;
Kohout et al., 2001; Qian et al., 2001). The functions of
 
 
 
-arrestins, 
 
 
 
2-adaptin, and dynamin have all been found to
involve binding to inositol lipids or inositol phosphates
(Gaidarov et al., 1999), and phosphoinositides have been
implicated at several steps in the endocytotic process
(Achiriloaie et al., 1999; Bottomley et al., 1999; Gaidarov
and Keen, 1999). Studies with muscarinic and 
 
 
 
-adrenergic
receptors indicated that phosphorylation of lipids by phos-
phatidylinositol (PI) 4-kinase(s) is required for the internal-
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ization of GPCRs (Sorensen et al., 1998, 1999). However,
recent studies have suggested that GPCR kinase–mediated
translocation of a PI 3-kinase to membranes may mediate this
effect (Naga Prasad et al., 2001).
Although considerable progress has been made in defining
the mechanisms involved in intracellular processing of in-
ternalized nutrient and growth factor receptors (Mellman,
1996), less information is available about the trafficking and
fate of internalized GPCRs. Studies on numerous GPCRs
have shown that most internalized receptors recycle to the cell
surface and utilize a variety of trafficking pathways during this
process. For example, the 
 
 
 
2
 
-adrenergic receptor undergoes
relatively rapid recycling to the surface via a route that requires
a conformational change induced by acidification in the endo-
somes and subsequent dephosphorylation (Lefkowitz, 1998).
Recent studies have demonstrated that GPCRs are also found
in perinuclear recycling endosomes during their intracellular
trafficking steps (Innamorati et al., 2001; Kreuzer et al., 2001;
Schmidlin et al., 2001; Signoret et al., 2000).
Studies on the yeast mating factor receptor suggest that deg-
radation of the internalized receptor via ubiquitination in-
volves sorting into a lysosomal compartment that is also a part
of the vacuolar sorting pathway from the Golgi apparatus
(Katzmann et al., 2001; Simonsen et al., 2001). Both the sort-
ing of molecules into this compartment and their exit there-
from depend on the function of Vps34p, the sole PI 3-kinase
of yeast (Schu et al., 1993; Simonsen et al., 2001). The forma-
tion of PI 3-phosphate (PI[3]P) by Vps34p is required for
membrane targeting of the early endosomal autoantigen 1
(EEA1), which promotes Rab5-mediated homotypic fusion of
early endosomes (Simonsen et al., 2001). Moreover, further
phosphorylation of PI(3)P by a 5-kinase, Fab1p, is necessary
for the formation and processing of multivesicular bodies
(MVBs) (Odorizzi et al., 1998). The functions of inositide ki-
nases and phosphoinositides are also required for the endoso-
mal processing of internalized growth factor and transferrin
receptors (TfRs) (Corvera and Czech, 1998; Simonsen et al.,
2001). However, little is known about the specific mecha-
nisms by which phosphoinositides determine the endosomal
processing of GPCRs in mammalian cells.
The aim of the present study was to characterize the intra-
cellular compartments through which the internalized AT
 
1
 
R
is processed, and to investigate the role of PI 3-kinases in the
pathway(s) involved in AT
 
1
 
R trafficking. Our results indicate
that PI 3-kinase inhibitors selectively impair a step in the pro-
cessing of internalized AT
 
1
 
R by which the receptor rapidly re-
cycles to the membrane from vesicles that resemble MVBs.
We also demonstrate the presence of a slower process that oc-
curs via recycling endosomes and is still operative in the pres-
ence of PI 3-kinase inhibitors. Based on these findings, we
propose a model of the postendocytic trafficking of the AT
 
1
 
R
that involves at least two major pathways of GPCR recycling.
 
Results
 
Properties of the AT
 
1
 
R–GFP chimera
 
Green fluorescent protein (GFP) fusion proteins have been
used to study the intracellular trafficking of several GPCRs,
Figure 1. Functional properties of the GFP-tagged AT1R 
expressed in HEK 293 cells. (A) Cytoplasmic Ca
2  signal 
after addition of Ang II to Fura-2–loaded cells. (B) Inositol 
phosphate production (mean   SEM; n   3) of cells 
expressing AT1R–GFP or a FLAG-tagged AT1R in response 
to Ang II (100 nM). (C) Ang II-induced phosphorylation of 
wild-type and GFP-tagged AT1R, and their mobility 
change after deglycosylation by peptide N-glycosidase F. 
(D) Distribution of GFP-tagged AT1R stably transfected in 
HEK 293 cells. Confocal images are shown either through 
a cross section (top) or on the surface (bottom) of the 
cells. In addition to the plasma membrane, there is a clear 
signal in intracellular membranes, most notably in the 
nuclear envelope and the pericentriolar compartment. 
Bars, 10  m. 
PI 3-kinase dependence of AT
 
1
 
 
 
receptor trafficking |
 
 Hunyady et al. 1213
 
including the AT
 
1
 
R (Kallal and Benovic, 2000; Chen et al.,
2001; Miserey-Lenkei et al., 2001). In the present study,
HEK 293 cells were stably transfected with a fusion protein
consisting of the AT
 
1
 
R and GFP. Ang II stimulation evoked
a characteristic cytoplasmic [Ca
 
2
 
 
 
] signal and an inositol
phosphate response similar to those induced by the wild-
type receptor (Fig. 1, A and B), indicating the functional in-
tegrity of the tagged receptor. Because phosphorylation of
the cytoplasmic tail is a major determinant of the intracellu-
lar trafficking of the AT
 
1
 
R and other GPCRs, the extent to
which fusion of a GFP tag to the COOH terminus of the re-
ceptor affected its phosphorylation was also investigated. As
shown in Fig. 1 C, Ang II caused prominent phosphoryla-
tion of the wild-type AT
 
1
 
R receptor expressed in HEK cells,
typically with several diffuse bands over the 70–200 kD mol
wt range that reflects the extensive glycosylation of the re-
ceptor (Smith et al., 1998). Accordingly, after deglycosyla-
tion with peptide 
 
N
 
-glycosidase F, the receptor was detected
as a more compact 40-kD band (Fig. 1 C). Phosphorylation
of the AT
 
1
 
R–GFP fusion protein showed a similar pattern
(Fig. 1 C), except that the molecular weights of the intact
and deglycosylated AT
 
1
 
R–GFP receptors were higher due to
the addition of GFP.
On confocal microscopy, the green AT
 
1
 
R was found pre-
dominantly in the plasma membrane in resting HEK 293
cells. However, intracellular localization of the fusion pro-
tein was also detectable, especially in cells showing higher
levels of receptor expression (Fig. 1 D). In many cells, the re-
ceptor was present in the nuclear envelope, but intranuclear
localization of the receptor was never observed (Fig. 1 D,
top). Receptor expression was also very prominent in cell
surface extensions (Fig. 1 D, bottom).
 
Colocalization of fluorescent agonist with the AT
 
1
 
R 
during endocytosis
 
To follow the fate of the receptor and its ligand simulta-
neously in live cells, rhodamine-labeled fluorescent Ang II
(Rhod–Ang II) was used to stimulate cells expressing the
AT
 
1
 
R–GFP chimera. Rhod–Ang II was rapidly bound to cell
surface receptors (Fig. 2 A) and caused clustering of the recep-
tors on the plasma membrane within a few minutes (Fig. 2 B).
During the subsequent internalization of the hormone–recep-
tor complex, both ligand and receptor were detectable in
punctate intracellular structures (Fig. 2 C). Progressive inter-
nalization of the receptor, and its colocalization with the
ligand, were evident for up to 30 min (Fig. 2 D). At this time,
the receptor and its ligand began to appear in deeper compart-
ments adjacent to the nucleus, in addition to the more periph-
eral vesicles (Fig. 2, D and E). At these later times, Rhod–Ang
II was also detectable in small punctate structures that did not
contain the receptor (Fig. 2, D and E). Most cells showed ex-
tensive accumulation of the AT
 
1
 
R–GFP chimera in colocal-
ization with its fluorescent ligand in the juxtanuclear compart-
ment after 1 h of incubation with Rhod–Ang II (Fig. 2 E).
 
Compartments involved in the endosomal processing 
of the AT
 
1
 
R–GFP chimera
 
Fluorescent markers were used to characterize the intracellu-
lar compartments that contained Ang II and the AT
 
1
 
R dur-
ing their individual trafficking steps. Early endosomes were
identified by the use of a GFP-tagged FYVE domain
(FYVE–GFP) of the EEA1, and GFP-tagged Rab proteins
were used to identify individual recycling compartments.
The FYVE domain construct used in the present study
(amino acids 1252–1411) contains part of the adjacent
Rab5 binding domain of the EEA1 protein and thereby la-
bels early endosomes, due to its simultaneous binding of
PI(3)P and Rab5 in this compartment (Gillooly et al.,
2000). The GFP constructs were transiently expressed in
HEK 293 cells stably transfected with either wild-type or
HA-tagged AT
 
1
 
R. Soon after the addition of Rhod–Ang II,
a significant proportion of the internalized ligand showed
colocalization with the FYVE–GFP construct in early endo-
somes (Fig. 3 A, top). No increase was observed in the num-
ber of FYVE–GFP-positive vesicles after stimulation with
Ang II. Treatment with wortmannin (WT) caused rapid dis-
sociation of the GFP-tagged FYVE domain from its punc-
Figure 2. Internalization of Rhod–Ang II in HEK 293 cells stably 
expressing the AT1R–GFP. Confocal images show the distribution of 
receptors (green) and the ligand (red) at selected times after stimulation 
with Rhod–Ang II (50–100 nM) at 37 C. Note the colocalization of 
receptors and ligand at early times of stimulation (A and B, arrows) 
and the subsequent appearance of vesicles containing only the 
ligand after prolonged incubation (D and E, arrows). Bar, 10  m. 
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tate sites without affecting the association of already inter-
nalized Rhod–Ang II with the early endosomes (Fig. 3 A,
bottom). Both Rhod–Ang II (in live cells) and HA epitope–
tagged AT
 
1
 
R (in fixed cells) were found in Rab5-positive
vesicles after short incubations (Fig. 3 B), consistent with
the recently reported role of Rab5 during the initial process-
ing of the internalized AT
 
1
 
R in early endosomes (Seachrist
et al., 2002).
After 15 min, localization of Rhod–Ang II as well as the
HA-tagged AT
 
1
 
R was also observed in vesicles containing
Rab4 (Fig. 3 C). However, only after more prolonged incu-
bations (
 
 
 
30 min) was the ligand and receptor found in
juxtanuclear vesicles positive for Rab11 (Fig. 4 A). The
amount of red fluorescent ligand detected in the latter com-
partment was greatly reduced in cells expressing dominant-
negative Rab11S25N–GFP (Fig. 4 B). The prominent colo-
calization of AT
 
1
 
R–GFP with Alexa
 
®
 
594–Tf in the juxtanu-
clear compartment was also consistent with the passage of
internalized AT
 
1
 
R through pericentriolar recycling endo-
somes (Trischler et al., 1999; Fig. 4 C).
 
WT-induced morphological changes in compartments 
involved in AT
 
1
 
R trafficking
 
When HEK 293 cells stably transfected with the AT
 
1
 
R–
GFP chimera were treated with 1 
 
 
 
M WT, stimulation
with Rhod–Ang II for 60 min caused prominent accumu-
lation of large vesicles that contained Rhod–Ang II in their
lumens, and the receptor (often with its associated ligand)
in their limiting membranes (Fig. 5 A). In many of the
large vesicles containing Rhod–Ang II, more intense and
rapidly moving small red dots were attached to their mem-
branes and often within their lumens (Fig. 5 B). The pro-
gressive accumulation of large vesicles was paralleled by a
decrease in the small vesicles containing only the ligand
without AT
 
1
 
R–GFP in the cell periphery (Fig. 5, A vs. E),
suggesting an impairment of the separation of this com-
partment from the larger vesicular pool. Because the ma-
jority of the small peripheral vesicles containing only the
ligand without AT
 
1
 
R–GFP did not colocalize with the ly-
sosomal marker, Lysotracker (unpublished data), these
structures may represent recycling vesicles. Despite the
marked alteration in the endosomal processing of the
AT
 
1
 
R in WT-treated cells, colocalization of some Rhod–
Ang II and AT
 
1
 
R in the juxtanuclear compartment was still
evident after 60 min of exposure of the cells to the fluores-
cent agonist (Fig. 5 A). In dose dependence studies, the
morphological changes caused by 100 nM WT were al-
most as marked as those observed with 1 
 
 
 
M WT. How-
ever, no significant changes were observed at 10 nM and
only slight enlargement was detectable at 30 nM WT.
Treatment of cells with 100 
 
 
 
M LY 294002, a less potent
PI 3-kinase inhibitor, induced similar changes in morphol-
ogy (unpublished data).
 
Characterization of the vesicular pool enlarged in 
response to WT
 
To characterize the endosomal compartment that is enlarged
in WT-treated cells, GFP-tagged Rab proteins known to be
involved in the processing of endosomes were again ex-
pressed in HEK 293 cells stably transfected with the HA–
AT
 
1
 
R. After stimulation with Rhod–Ang II in the presence
of WT, some of the enlarged vesicles were found to contain
each of Rab4–GFP, Rab5–GFP, and Rab11–GFP (Fig. 6
A). Almost all vesicles contained the red fluorescent ligand,
often still attached to the receptor, at their limiting mem-
branes. The HA–AT
 
1
 
R was likewise also found to be associ-
ated with enlarged vesicles containing either Rab5–GFP
(unpublished data), Rab4–GFP, or Rab11–GFP, and was
colocalized with Rab11 in the juxtanuclear recycling com-
partment (Fig. 6 B). Fluorescent Ang II was also present in
large vesicles that contained Rab7–GFP in their limiting
membranes (Fig. 6 A). These data demonstrate that WT did
not prevent the association of these three Rab proteins with
endocytic membranes.
Figure 3. Localization of AT1R and selected fluorescent markers 
after Ang II stimulation in HEK 293 cells. HEK 293 cells expressing 
the wild-type or HA-tagged AT1R were transiently transfected with 
the GFP-fused FYVE domain of EEA1, or GFP-fused Rab4 and Rab5 
proteins. After 24 h, cells were stimulated with Rhod–Ang II (B and 
C, left) or Ang II (right) for 15 min at 37 C. Appearance of Rhod–Ang 
II in FYVE–GFP- (A) and Rab5–GFP-positive (B) early endosomes is 
apparent at this time. Addition of 1  M WT causes rapid dissociation 
of FYVE–GFP from the early endosomes (A, bottom). Rhod–Ang II 
also appears in Rab4–GFP-positive vesicles shortly after stimulation 
(C). Similar localization of the HA–AT1R was observed by immuno-
staining of the receptor in fixed cells (B and C, right). Bars, 10  m. 
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Because large vesicles were also found in WT-treated
cells without Ang II stimulation (although without AT
 
1
 
R–
GFP in their wall), we examined the distribution of TfR in
WT-treated cells by using Alexa
 
®
 
-labeled Tf in live cells, or
by immunostaining the TfR in fixed cells. Fluorescent Tf
was present in the membranes of only a minority of the
large vesicles of WT-treated cells, often in colocalization
either with Rab4, Rab5, or Rab11, but never with Rab7
(Fig. 6 C). Unlike Ang II, Tf was not found within the lu-
men or inside the small vesicular compartment within the
large vesicles. However, it was occasionally present in their
limiting membrane and in smaller vesicles often still at-
Figure 4. Localization of the AT1R and Rhod–Ang II in 
juxtanuclear recycling endosomes after prolonged Ang II 
stimulation in HEK 293 cells. Cells stably expressing 
AT1R were transfected with Rab11–GFP (A, left) or 
Rab11-S25N–GFP (B) or the HA-tagged AT1R was 
coexpressed with Rab11–GFP (A, right). After 24 h, cells 
were stimulated with Rhod–Ang II or Ang II for 1 h at 
37 C as indicated. Colocalization of both the ligand and 
the receptor with Rab11 in juxtanuclear compartments 
can be observed (A), and the accumulation of the ligand 
in this compartment is greatly reduced in cells expressing 
Rab11-S25N–GFP (B). The juxtanuclear area void of 
Rhod–Ang II is pointed out by an arrow (B, right). (C) 
Cells expressing the AT1R–GFP were stimulated with 
unlabeled Ang II (100 nM) and Alexa
®594-conjugated Tf 
for 60 min. After washing, cells were further incubated for 
15 min to chase Tf from the early endosomes. Note the 
prominent colocalization of AT1R and Tf in the juxtanuclear 
compartment (arrows). Bars, 10  m.
Figure 5. Effect of WT treatment on the local-
ization of internalized AT1R. (A) Cells expressing 
AT1R–GFP were stimulated with Rhod–Ang II 
for 60 min after a 10-min pretreatment with 1 
 M WT. Note the significant reduction of 
receptors at the cell surface and the development 
of large vesicles containing the receptor still 
bound with its ligand in their walls. (B) Local-
ization of small vesicles (arrows) containing 
Rhod–Ang II within the large vesicles that 
accumulate after stimulation by Ang II for 30 
min in the presence of WT. Bars, 10  m. 
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Figure 6. Localization of Rhod–Ang II, AT1R, Alexa
®–Tf, and 
individual Rab–GFP proteins in HEK 293 cells after WT treatment. 
Cells expressing HA–AT1R and the respective Rab–GFP constructs 
were pretreated with 1  M WT and incubated with Rhod–Ang II (A), 
Ang II (B), or Alexa
®-conjugated Tf (C) for 30 min. After WT treat-
ment, Rhod–Ang II can be found in multiple vesicles, some of which 
are positive for any of the four Rab–GFP proteins tested (A). The
immunostained HA–AT1R is also found in association with Rab4–
GFP-containing large vesicles and with the Rab11-positive juxta-
nuclear compartment (B). (C) Alexa
®–Tf can be found in the limiting 
membranes (but not in the lumens) of Rab4-, Rab5-, and Rab11-
positive vesicles, but not in those positive for Rab7. Bars, 10  m.
Figure 7. Localization of Rhod–Ang II, HA–AT1R, and Alexa
®–
Tf in HEK 293 cells expressing Rab5Q79L or Rab5S34N. Cells 
expressing wild-type or HA–AT1R and the respective mutant form 
of Rab5–GFP or only AT1R–GFP were stimulated with Rhod–Ang 
II or Ang II for 30 min. In cells expressing Rab5Q79L–GFP, Ang II 
stimulation leads to the formation of large clusters containing 
both the ligand (A, top left) and the immunostained HA–AT1R 
(A, bottom left) within large vesicles. These clusters are not 
observed in WT-treated cells (A, top right). Alexa
®-Tf is only 
present in the limiting membranes but not in the lumen of the 
large vesicles (A, bottom right). Expression of Rab5S34N (B, 
top) or treatment with 100 nM bafilomycin (Bfm; B, bottom) 
prevents the formation of large vesicles after WT treatment. 
Bars, 10  m.PI 3-kinase dependence of AT1 receptor trafficking | Hunyady et al. 1217
tached to the larger vesicles (Fig. 6 B). Similar results were
obtained after immunostaining with the anti-TfR antibody
(unpublished data).
When the GTP-bound mutant version of Rab5
(Rab5Q79L) was expressed in HEK 293 cells, large vesicles
similar to those formed after WT treatment in control cells
were observed (Fig. 7 A). However, a notable feature of the
Rab5Q79L-induced large vesicles, as opposed to those of
WT-treated cells, was the presence of large Rhod–Ang II-
and AT1R-containing clusters within their lumens (Fig. 7
A). Such clusters were not observed in cells incubated with
Rhod–Ang II after WT treatment and only the large vesicle–
associated small red dots characteristic of WT-treated cells
were present (Fig. 7 A). In contrast, expression of the GDP-
bound mutant, Rab5S34N, prevented the formation of large
vesicles after Ang II and WT treatment. The amount of in-
ternalized Rhod–AngII was greatly reduced in such cells af-
ter 30 min of incubation, although the initial internalization
of AT1R was still observed (Fig. 7 B). Pretreatment of cells
with the H
 -ATPase inhibitor bafilomycin (100 nM) com-
pletely prevented the separation of AT1R and its ligand (Fig.
7 C, left) and abolished the formation of the large vesicles in
WT-treated cells, leading to the accumulation of the Rhod–
Ang II and the AT1R in the juxtanuclear compartment (Fig.
7 C, right).
WT inhibits rapid, but not slow, recycling 
of the AT1R to the cell surface
The inhibitory effect of WT on some, but not all, aspects of
AT1R trafficking, and the association of multiple Rab pro-
teins with the enlarged vesicles, suggested that recycling of
the receptor to the cell surface occurs via multiple pathways.
To assess the consequences of the WT-induced vesicular
changes on the cell surface receptor population, binding
studies were performed with 
125I-[Sar
1Ile
8]Ang II. As ex-
pected, incubation of cells with Ang II for 30 min caused a
significant decrease in the abundance of AT1R on the cell
surface (Fig. 8 A), as measured by radioligand binding. To
analyze the process of receptor recovery and the involvement
of PI 3-kinase(s), after 30 min of Ang II treatment, the
ligand was removed by thorough washing and the cells were
incubated for the indicated times in the presence or absence
of WT. Subsequent quantitation of cell surface receptors by
radioligand binding revealed that the reduced number of cell
surface receptors in control cells showed progressive recovery
after removal of the ligand, reaching pretreatment levels by
75 min and continuing to rise for up to 150 min (Fig. 8 A).
However, in WT-treated cells, the recovery of sequestered
AT1R at the cell surface was significantly inhibited during
the first 30 min after removal of Ang II, but thereafter pro-
ceeded at the same rate as in control cells despite the contin-
ued presence of WT (Fig. 8 A). The lack of effect of WT on
the slow recovery phase was not due to WT degradation, be-
cause similar results were obtained when WT was added ev-
ery 30 min for up to 2 h (unpublished data). These findings
suggest that the restoration of AT1 receptors at the cell sur-
face is mediated by a rapid, WT-sensitive mechanism and by
a slower process that still operates after WT treatment. The
concentration-dependent actions of two PI 3-kinase inhibi-
tors on the early component of AT1R recycling are shown in
Fig. 8 B. These are in good agreement with the respective
potencies of the inhibitors in exerting their morphological
effects, indicating the involvement of PI 3-kinase(s) in the
process of AT1R recycling.
The effect of WT on a single cycle of the processing of
prebound 
125I-Ang II ligand was examined in cells expressing
the AT1R–GFP chimera. Cells were prelabeled with 
125I-Ang
II on ice to prevent internalization and incubated with or
without 1  M WT for the last 10 min of incubation. After
washing at 4 C to remove the unbound ligand, cells were in-
cubated in the absence or presence of WT at 37 C for the
indicated times, and the internalized and extracellular frac-
tions of bound 
125I-Ang II were determined (see Materials
and methods). WT had no effect on the rapid intracellular
accumulation of 
125I-Ang II during the internalization phase
(first 5 min) of the incubation (Fig. 8 C). However, during
the subsequent 10 min, the internalized label was cleared
more rapidly from control cells than from those treated with
Figure 8. Changes in cell surface AT1R abundance as assessed by 
125I-[Sar
1,Ileu
8]Ang II. (A) Cells expressing GFP-tagged AT1R were 
stimulated with Ang II (1  M) for 30 min (labeled as 0 min) and the 
cells were thoroughly washed before further incubation without the 
ligand for the indicated times. At selected time points, cells were 
placed on ice and surface receptors were determined by 12-h bind-
ing with the iodinated antagonist ligand at 4 C. When added, WT 
was present during the last 10 min of the 30-min Ang II treatment. 
(B) Dose dependence of the inhibitory effect of WT and LY 294002 
on the recycling of AT1R measured at the 30 min time point of the 
plot shown in panel A. (C) Appearance of acid-resistant (internalized) 
125I-Ang II binding as a function of time in a one-cycle internalization 
at 37 C of cell surface receptors preloaded with the iodinated 
agonist at 4 C.1218 The Journal of Cell Biology | Volume 157, Number 7, 2002
WT (Fig. 8 C). Furthermore, the intracellular ligand was
eventually slowly cleared from the WT-treated cells as well.
These data indicate that WT does not affect the process of
endocytosis of the AT1R, but causes selective inhibition of
the early recycling process of both the receptor and its
ligand.
Finally, the WT sensitivity of the recycling of 
125I-Tf was
examined by a similar approach to analyze one single cycle
of prebound Tf, and in the conventional way by preloading
cells with 
125I-Tf for 30 min at 37 C and following the exit
of internalized Tf in the presence or absence of WT. WT al-
most completely prevented the recycling of 
125I-Tf in the
one-cycle experiment (Fig. 9 A), but only partially inhibited
the recycling of Tf that was loaded into the cells at 37 C
during prolonged incubation (Fig. 9 B).
Discussion
The present study has provided a detailed analysis of AT1R
endocytosis and trafficking, and the effects of PI 3-kinase in-
hibition on the processing pathways of the internalized
ligand–receptor complex. After addition of Ang II, the
AT1R and its ligand formed clusters at the cell surface and
rapidly appeared in early endosomes. This was indicated by
their colocalization with a GFP-tagged FYVE domain, and
with the Rab5 protein as recently described by Seachrist et
al. (2002). As predicted, WT treatment caused rapid dissoci-
ation of the FYVE domain from this compartment. This
might be expected to alter the function of early endosomes
because both the heterotypic fusion of endocytic vesicles
with endosomes and the homotypic fusion of early endo-
somes require tethering by the EEA1 protein (Christoforidis
et al., 1999). However, the ability of this step to proceed af-
ter WT treatment is probably due to the interaction of
EEA1 with Rab5 even without PI(3)P, as recently observed
during processing of the epidermal growth factor (EGF) re-
ceptor (Chen and Wang, 2001b). Accordingly, WT concen-
trations of up to 10  M had no effect on agonist-induced
endocytosis of either the AT1R or the TfR. The latter is con-
sistent with previous reports that inhibition of PI 3-kinases
did not impair the initial rate of TfR endocytosis (Martys et
al., 1996; Spiro et al., 1996). The agonist-dependent recruit-
ment of a PI 3-kinase to the cell membrane has been re-
cently proposed to play a role in  2-adrenergic receptor se-
questration (Naga Prasad et al., 2001). However, other
studies have suggested that the inhibitory effect of high WT
concentrations on the endocytosis of  2-adrenergic and
muscarinic receptors is caused by inhibition of type III PI
4-kinases rather than PI 3-kinases, with consequent deple-
tion of the plasma membrane PI 4,5-bisphosphate pool (So-
rensen et al., 1998, 1999).
The processing of nutrient receptors from early endo-
somes has been well characterized and is known to involve
the small GTP binding proteins Rab4, Rab5, and Rab11.
Rab4 is believed to provide rapid recycling of receptors to
the surface from Rab5-positive sorting endosomes, whereas
Rab11 is believed to be involved in the recycling from the
more slowly appearing juxtanuclear compartment often re-
ferred to as the recycling endosomes (Mellman, 1996). Dur-
ing maturation of the latter compartment, Rab4 and Rab11
proteins often appear together (Miaczynska and Zerial,
2002). The WT sensitivity of Tf recycling, found in experi-
ments using tracer amounts of 
125I-Tf and a “one-cycle” pro-
tocol, indicates that a large fraction of internalized TfRs re-
cycle through a WT-sensitive mechanism. Only after longer
incubations at 37 C does Tf reach a compartment from
which Tf recycling occurs even in the presence of WT.
These data are consistent with a model in which Rab4-
dependent rapid cycling of TfR from sorting endosomes is
more sensitive to PI 3-kinase inhibition than the route of
Rab11-dependent recycling endosomes. The Tf receptors
found in the latter compartment become loaded with Tf
only after prolonged internalization or at high receptor oc-
cupancy (Trischler et al., 1999).
Our data on the colocalization of AT1R with Rab4- and
Rab11-containing vesicles indicate that the AT1R also uses
both of these mechanisms for receptor recycling. Processing
of internalized AT1R from early endosomes showed several
features that differ from those of the TfR. First, even in one-
cycle experiments, only the most rapid fraction of the 
125I-
Ang II recycling was inhibited by WT and a significant frac-
tion of the ligand was able to leave the cells. Similarly, only
the rapid phase of AT1R recovery to the cell surface after ter-
mination of Ang II stimulation was sensitive to WT. These
kinetic data were paralleled by morphological differences
Figure 9. Recycling of surface-bound or already internalized 
125I-Tf in HEK 293 cells. HEK 293 cells expressing AT1R–GFP were 
incubated with 
125I-Tf either on ice (A) or at 37 C (B) for 90 and 30 
min, respectively. After washing off the unbound ligand, cells were 
incubated at 37 C for the indicated period of time, and the distribution 
of the tracer between the medium, cell surface, and cell interior was 
determined as detailed in the Materials and methods section. Re-
entry of externalized Tf was prevented by the addition of desferrox-
amine (100  M) and unlabeled Tf after 5 min (A) or from 0 min (B).PI 3-kinase dependence of AT1 receptor trafficking | Hunyady et al. 1219
that became appreciable only after WT treatment. In the
case of the AT1R, separation of a significant portion of the
ligand from its receptor occurs by a WT-sensitive process
that causes the appearance of both the receptor and its
ligand in small vesicles within the larger WT-induced vesi-
cles. Neither Tf nor its receptor is detected inside such en-
larged vesicles, but they were occasionally found in the limit-
ing membranes of the larger vesicles and in tiny vesicles
associated with the latter. The vesicular structures observed
after Ang II stimulation in the presence of WT were similar
to the MVBs, in which inward membrane budding leads to
the formation of small internal vesicles (Mellman, 1996).
MVBs that are positive for Rab7 are known to process recep-
tor tyrosine kinases, such as the EGF receptor, and appear to
be the sorting organelles for proteins destined for lysosomal
degradation (Felder et al., 1990; Mellman, 1996). However,
kinase-deficient EGF receptors, unlike their wild-type coun-
terpart, do not undergo lysosomal degradation and return to
the plasma membrane (Felder et al., 1990). This suggests
that receptors can recycle back to the cell surface from
this organelle or from its precursor forms. A recent report
also demonstrated the presence of the G protein–coupled
m4 muscarinic receptor (but not of TfR) inside small vesi-
cles within large endosomes formed in cells expressing
Rab5Q79L, a structure considered by the authors to be the
MVB (Volpicelli et al., 2001).
Several lines of evidence have indicated that protein sorting
at the level of the MVB is dependent on PI 3-kinase prod-
ucts. In Saccharomyces cerevisiae, the formation of PI(3,5)P2
from PI(3)P by the Fab1p protein, a PI(3)P 5-kinase, is nec-
essary for the inward invagination of membranes and forma-
tion of internal vesicles (Odorizzi et al., 1998). In mamma-
lian cells, injection of an antimammalian Vps34p antibody
inhibited internal vesicle formation in multivesicular endo-
somes (Futter et al., 2001). Other evidence indicates that PI
3-kinases are also involved during the formation of late endo-
somes and lysosomes (Fernandez-Borja et al., 1999). WT also
induced morphological changes similar to those described in
the present report during studies on the delivery of lysosomal
enzymes mediated by the mannose 6-phosphate receptor
(Brown et al., 1995). Our data on the heterogeneity of the
large vesicles observed in WT-treated and Ang II–stimulated
HEK cells are consistent with multiple defects in the process-
ing of early endosomes as well as the MVB. These include the
budding off of external vesicles (used by TfR and perhaps a
fraction of the AT1R) as well as the formation of internal ves-
icles and the maturation toward late endosomes via MVBs.
Inhibition of these processes by WT could contribute to the
enlargement of internalized vesicles. Although the WT-sensi-
tive component of AT1R recycling could represent the same
Rab4-dependent pathway used by the TfR, it may also in-
volve a process by which the receptor is retrieved from multi-
vesicular compartments before maturation to late endosomes.
It is likely that this route (even if not identical with the path-
way of TfR recycling) also utilizes Rab4, because we clearly
detected colocalization of Rhod–Ang II and the HA–AT1R
with Rab4–GFP. The G protein–coupled  2 adrenergic re-
ceptor, which is known to use a rapid recycling route, has also
been shown to recycle to the cell surface via a Rab4-depen-
dent mechanism (Seachrist et al., 2000).
It is important to note that WT treatment had relatively
minor effects on the slow component of AT1R recycling,
and under these conditions both receptor and ligand were
found in small juxtanuclear vesicles. This suggests that some
small vesicles still can be formed, and that these probably
represent the route through which receptor and ligand can
recycle after WT treatment. Several observations suggest
that this compartment is the Rab11-positive recycling endo-
some. The AT1R was found to colocalize with Alexa
®–Tf in
the pericentriolar area of Ang II–stimulated cells even after
WT treatment. Given the relative WT insensitivity of TfR
recycling from the Rab11-positive recycling endosomal
compartment, it is probable that AT1R recycling from the
enlarged vesicles involves the same route. However, it is also
possible that the slow recycling route observed in WT-
treated cells is a distorted pathway that shares only some of
the characteristics of the pathways occurring in normal cells.
The preservation of the slow recovery phase of internalized
receptors to the cell surface in WT-treated cells indicates
that lysosomal degradation of the AT1R is not a major route
in these cells, at least in the 2-h time frame of stimulation in
the present experiments. We also could not detect the AT1R
receptor (only the Rhod–Ang II ligand) in Rab7-positive
vesicles in WT-treated cells, consistent with the retrieval of
the receptor before late endosomes.
The similarity of the large vesicular phenotype between
WT treatment and Rab5Q79L expression, and the inability
of added 3-phosphoinositides to reverse the large vesicular
phenotype, has suggested that this effect of WT results from
inhibition of Rab5 inactivation rather than PI 3-kinase ac-
tivity (Chen and Wang, 2001a). However, although hydro-
lysis of Rab5-bound GTP may well be prevented by WT-
sensitive mechanisms, our data suggest that the effect of WT
is more complex than stabilization of Rab5GTP. The ability
of Rab5S34N to prevent the formation of large vesicles after
WT treatment indicates the need for continuous Rab5-
assisted transfer of the receptor–ligand complex from inter-
nalized vesicles to early endosomes. However, not all of the
enlarged vesicles contained wild-type Rab5–GFP in WT-
treated cells, suggesting that Rab5 must be released from at
least some of the vesicles despite the presence of WT. More-
over, Rab5Q79L caused the accumulation of large clusters
of Rhod–Ang II and HA–AT1R within the enlarged vesicles,
a feature that was not seen in vesicles of WT-treated cells.
Furthermore, although expression of Rab5Q79L was with-
out effect on TfR recycling (Ceresa et al., 2001; Volpicelli
et al., 2001), we observed that WT treatment inhibits early
recycling of the AT1R. These data suggest that although
the abnormal vesicles induced by WT or expression of
Rab5Q79L share many similarities, they are not identical.
Inhibition of H
 -ATPase by bafilomycin prevented the sep-
aration of AT1R from its ligand, and also prevented the WT-
induced enlargement of AT1R-containing vesicles. These
findings are similar to those observed with major histocom-
patibility complex (MHC) class II molecules in melanoma
cells (Fernandez-Borja et al., 1999), and indicate that acidifi-
cation is a prerequisite for the maturation of endosomes as
well as for the dissociation of the ligand–receptor complex.
Based on the present results and data available in the liter-
ature, a proposed model depicting the intracellular traffick-1220 The Journal of Cell Biology | Volume 157, Number 7, 2002
ing of AT1R and possibly other GPCRs is shown in Fig. 10.
Agonist-induced internalization of the AT1R is rapidly fol-
lowed by its appearance in early endosomes. Unlike the TfR,
which leaves early endosomes and recycles via Rab4- and
Rab11-positive recycling pathways, most of the AT1R ini-
tially follows a route leading to the formation of MVBs.
Some of the AT1R and its ligand could bud off by a mecha-
nism that is similar to that of the TfR. However, both can
leave the vesicles by other means and may utilize mecha-
nisms that are also involved in the formation of small inter-
nal vesicles. WT treatment causes multiple defects in early
endosome maturation and processing. These include the in-
hibition of early recycling of TfR, probably via Rab4, with
less impairment of the Rab11-positive slower recycling path-
way. WT also inhibits the processing of AT1R toward the
MVB, leading to the enlargement of this vesicular pool that
contributes to the inhibition of recycling of receptor and
ligand to the surface. The slow recycling of the receptor dur-
ing WT treatment involves a distinct mechanism that pro-
ceeds via the Rab11 recycling pathway. Further studies are
required to pinpoint the exact site(s) and enzyme(s) that are
targeted by WT, and to validate the relevance of this model
to the trafficking of other GPCRs.
Materials and methods
Materials and DNA constructs
The cDNAs of the rat vascular smooth muscle AT1A receptor, and type A
cholecystokinin receptor–GFP were provided by K.E. Bernstein (Emory
University, Atlanta, GA) and S.A. Wank (National Institute of Diabetes and
Digestive and Kidney Diseases), respectively. Rhod–Ang II was obtained
from NEN Life Science Products. 
125I-Ang II, 
125I-[Sar
1, Ile
8]Ang II, and 
125I-
Tf were purchased from NEN Life Science Products. Lysotracker, Al-
exa
®594–Tf and the Alexa
®594 secondary antibody were from Molecular
Probes. The chimeric AT1R–GFP chimera was constructed by linking the
cDNA of an enhanced fluorescent mutant of GFP (EGFP) (Tarasova et al.,
1997) to the 3  end of the coding region of the AT1R. The FYVE–GFP plas-
mid was created by subcloning the human EEA1 cDNA sequence (amino
acids 1252–1411) between the BglII and EcoRI sites of the pEGFP–C1 plas-
mid. GFP-tagged versions of the Rab proteins (Rab4, Rab5, Rab7, and
Rab11) were created in the pEGFP–C1 plasmids (CLONTECH Laborato-
ries, Inc.) after PCR amplification of the Rab proteins from cDNAs pre-
pared from MDCK cells. Mutations were generated with two-step PCR. All
constructs were verified with dideoxy sequencing.
Confocal analysis of receptor endocytosis
HEK 293 cells stably expressing the AT1R–GFP chimera were plated onto
polylysine-coated 25-mm-diameter glass coverslips at a density of 5   10
5
cells/dish and cultured for 3 d before analysis. HEK 293 cells stably ex-
pressing the wild type, HA–AT1R were transfected with selected GFP con-
structs using the lipofectamine reagent for 24 h. Cells were washed twice
with Dulbecco’s PBS containing 0.1% BSA before analysis and treated
with the indicated stimuli or inhibitors at 37 C. The coverslip was placed
into a chamber mounted on a heated stage with the medium temperature
kept at 33 C. Cells were incubated in 1 ml buffer and examined in an in-
verted microscope under a 40  oil immersion objective (Nikon) and a
Bio-Rad Laboratories laser confocal microscope (MRC-1024). For double
labeling experiments the 488- and 568-nm laser lines were used with
525   20-nm and 580-nm-long pass filters for the detection of GFP and
Alexa
®, respectively.
Immunocytochemistry
HEK 293 cells grown on glass coverslips were transiently transfected with
HA–AT1R and the respective Rab–GFP constructs for 24 h. Cells were stim-
ulated with Ang II for the times indicated and were washed twice with PBS
before fixation with 4% paraformaldehyde in PBS (pH 7.4) for 20 min at
room temperature. After treatment with sodium borohydride (1 mg/ml) for
15 min, cells were permeabilized with 0.1% Triton X-100 in PBS and incu-
bated in blocking solution for 30 min (1% BSA in PBS), before incubation
with anti-HA antibody (1:200 in blocking solution) for 1 h at room temper-
ature. This was followed by two washes with TBST and incubation with
rhodamine-conjugated anti–mouse antibody (1:200) for 1 h. The cover-
slips were mounted using Dako fluorescence mounting medium. Images
were acquired with a ZEISS LSM 510 confocal laser scanning microscope
in multi track mode, using the 488- and 543-nm laser lines with 500–550-
nm band pass and 560-nm long pass filters for the detection of GFP and
rhodamine, respectively.
Recycling of the AT1R in HEK 293 cells
HEK 293 cells stably expressing AT1R–GFP were cultured on 24-well
plates and preincubated in medium 199 (Hank’s salts) containing 20 mM
Hepes (pH 7.4) and 1 g/liter BSA in the absence or presence of Ang II (1
 M) for 30 min at 37 C. Cells were then washed four times with 1 ml ice
cold Dulbecco’s PBS, and the incubation continued for the indicated times
in medium 199 containing 20 mM Hepes (pH 7.4) and 1 g/liter BSA at
37 C. Inhibitors were added 10 min before the end of the preincubation
and were readministered with medium 199 after washing the cells to re-
move Ang II. Incubations were terminated by placing the cells on ice and
rapidly washing them twice with ice cold Dulbecco’s PBS. The surface
Figure 10. Trafficking steps after internalization 
of the AT1R. After ligand binding, AT1Rs undergo 
clustering into clathrin-coated pits at the plasma 
membrane followed by endocytosis. After uncoat-
ing, endocytic vesicles fuse with early endosomes. 
Some of the internalized receptors are processed 
toward a compartment (most likely the MVB) 
where, due to acidification, the ligand dissociates 
and the receptor rapidly recycles back to the 
plasma membrane. During this process, some of 
the ligand is sorted into lysosomes and some is 
recycled with the receptor and leaves the cells. 
Inhibition of PI 3-kinases by WT attenuates this 
pathway, leading to the accumulation of an inter-
mediate vesicular compartment that contains the 
AT1R and its ligand. Internalized receptors also 
traffic toward a juxtanuclear recycling compartment, 
from which both the receptor and the ligand are 
processed slowly. This recycling pathway remains 
functional during WT treatment.PI 3-kinase dependence of AT1 receptor trafficking | Hunyady et al. 1221
binding of the AT1R was then determined at equilibrium by incubating the
cells in the presence of 
125I-[Sar
1,Ile
8]Ang II (0.05  Ci/well) and unlabeled
[Sar
1,Ile
8]Ang II (2 nM) at 4 C overnight. The cells were washed twice with
1 ml Dulbecco’s PBS before solubilization with 0.5 M NaOH, 0.05% SDS
for determination of cell-associated radioactivity.
Internalization kinetics of prelabeled AT1R or TfR
HEK 293 cells were cultured in four-well plates and were incubated in the
presence of 
125I-Ang II or 
125I-Tf (0.05  Ci/well) in 0.5 ml medium 199 con-
taining 20 mM Hepes (pH 7.4) and 1 g/liter BSA at 4 C for 4 h (Ang II) or
90 min (Tf) to permit binding to the cell surface receptors without internal-
ization. The unbound tracer was removed by washing the cells twice with
1 ml ice cold Dulbecco’s PBS. At this point, 0.5 ml warm (37 C) medium
was added, and the cells were incubated for the indicated times at 37 C to
allow receptor internalization and subsequent processing to proceed. In
the case of TfR studies, 100  M desferroxamine and 100 nM unlabeled Tf
was added after 5 min to prevent possible reuptake of the recycled ligand.
Incubations were terminated by placing the cells on ice, and the medium
containing the radioligand released during the incubation was collected
and replaced with 0.5 ml ice cold acid wash solution (150 mM NaCl and
50 mM acetic acid) to remove the surface-bound radioligand (Hunyady et
al., 1994). After a 10-min incubation on ice, the extracellular (acid sensi-
tive) tracer was collected. Cells were then lysed with 0.5 M NaOH and
0.05% SDS to determine the internalized (acid resistant) radioactivity. The
total binding was calculated as the sum of the released (into the medium),
extracellular (acid sensitive), and internalized (acid resistant) radioactivi-
ties. The internalized radioactivity was expressed as a percent of the total
binding at each time point. Recycling of internalized TfR was also studied
after loading cells with 
125I-Tf for 30 min at 37 C and following the release
of internalized 
125I-Tf at 37 C after washing off the noninternalized tracer
in the presence of desferroxamine.
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